Welcome to Oncorus. We are a biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients. While immunotherapies have improved outcomes for some patients, many patients unfortunately are not eligible for, or do not respond to, existing immunotherapies. At Oncorus, our goal is to enable more patients to respond to this revolutionary approach of harnessing the body’s immune system to tackle cancer.